Paper Details

  1. Home
  2. Paper Details

Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.

Author: AraiMasaki, FurusawaYoshihiko, HanyaYuki, HattoriNobutaka, KitagawaTadayuki, MochizukiHideki, NagaiMasahiro, TakahashiRyosuke, TakedaAtsushi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study examined the impact of rasagiline, a medication for Parkinson's disease, on health-related quality of life (HRQoL). Japanese patients treated with rasagiline reported better HRQoL outcomes on the emotional well-being domain of the Parkinson's Disease Questionnaire (PDQ-39) compared to placebo.
Paper Details　
Original Abstract of the Article :
Identifying the factors that influence health-related quality of life (HRQoL) is of great scientific interest, but a potential causal relationship between treatment and HRQoL has yet to be fully elucidated. Japanese patients reported better HRQoL outcomes on the Parkinson's Disease Questionnaire (PD...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789184/

データ提供：米国国立医学図書館（NLM）

Rasagiline and Parkinson's Disease Questionnaire (PDQ-39): Examining Emotional Well-being

This study investigates the impact of rasagiline, a medication used to treat Parkinson's disease, on emotional well-being, as measured by the Parkinson's Disease Questionnaire (PDQ-39). The study analyzed data from two clinical trials in Japan, examining the emotional well-being domain of the PDQ-39 in patients treated with rasagiline compared to placebo.

Rasagiline and Emotional Well-being: A Potential Link

The study found that Japanese patients treated with rasagiline reported better emotional well-being scores on the PDQ-39 compared to those who received placebo. This finding suggests a potential positive effect of rasagiline on emotional well-being in patients with Parkinson's disease. It's like finding a hidden oasis in the desert of Parkinson's disease, where emotional well-being can flourish.

Understanding the Role of Rasagiline in Emotional Health

The study provides valuable insights into the potential impact of rasagiline on emotional well-being in Parkinson's disease. However, further research is needed to confirm these findings and explore the underlying mechanisms involved. It's important to remember that each individual's experience with Parkinson's disease is unique, and treatment responses can vary. It's like navigating a desert with changing landscapes - what works for one person may not work for another. Close collaboration with a healthcare professional is essential for developing personalized treatment plans that address individual needs and optimize outcomes.

Dr. Camel's Conclusion

This study offers a glimpse into the potential benefits of rasagiline for emotional well-being in Parkinson's disease. It's like finding a hidden spring of emotional resilience in the midst of a challenging journey. More research is crucial to fully understand the relationship between rasagiline and emotional health, enabling us to better support the needs of patients with Parkinson's disease.

Date :
  1. Date Completed 2022-02-22
  2. Date Revised 2022-02-22
Further Info :

Pubmed ID

35077474

DOI: Digital Object Identifier

PMC8789184

Related Literature

Article Analysis
・Effects of rasagiline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.